All In MedTech

FDA Clearance Tracker · P020006

ENTERYX PROCEDURE KIT

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Apr 22, 2003 (this decision)Source: openFDAMethods & limitations

PMA

Decided

Apr 22, 2003

Approval withdrawn

Time to decision

435 days

Received Feb 11, 2002. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P020006
Device name
ENTERYX PROCEDURE KIT
Applicant location
Marlborough, MA
Received
Feb 11, 2002
Decided
Apr 22, 2003
Decision
Approval withdrawn
Supplements
4 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code LNM

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE ENTERYX PROCEDURE KIT. THE DEVICE IS INDICATED FOR ENDOSCOPIC INJECTION INTO THE REGION OF THE LOWER ESOPHAGEAL SPHINCTER (LES) FOR THE TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE (GERD) SYMPTOMS IN PATIENTS RESPONDING TO AND REQUIRING DAILY PHARMACOLOGICAL THERAPY WITH PROTON PUMP INHIBITORS.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code LNM. The earliest in FDA's data is P900030, decided Sep 30, 1993.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Boston Scientific Corp

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.